Selecta Biosciences Inc (SELB)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Carsten Brunn
Employees:
60
480 ARSENAL WAY, WATERTOWN, MA 02472
617-923-1400

Selecta Biosciences, Inc. engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as Sel-212 that is. in Phase III clinical trials for the. treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases.

Data derived from most recent annual or quarterly report
Market Cap 270.865 Million Shares Outstanding153.031 Million Avg 30-day Volume 782.939 Thousand
P/E Ratio6.0078 Dividend Yield0.0 EPS-0.18
Price to Revenue2.0229 Debt to Equity0.3073 EBITDA17.943 Million
Price to Book Value2.9523 Operating Margin21.878800000000002 Enterprise Value128.326 Million
Current Ratio6.73 EPS Growth1.49 Quick Ratio6.464
1 Yr BETA 1.3517 52-week High/Low 2.73 / 0.65 Profit Margin33.6712
Operating Cash Flow Growth-41.6621 Altman Z-Score0.3991 Free Cash Flow to Firm -69.191 Million
Earnings Report2023-03-09

Are you looking for this stock instead?

View SEC Filings from SELB instead.

View recent insider trading info

Selecta Biosciences Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding SELB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SELB

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-01-06 by BRUNN CARSTEN
  • 4: filed on 2023-01-06 by JOHNSTON LLOYD P.
  • 4: filed on 2023-01-06 by KISHIMOTO TAKASHI KEI
  • 4: filed on 2023-01-06 by TRABER PETER G
  • 4: filed on 2023-01-04 by MYERS SCOTT DUNSETH
  • 4: filed on 2023-01-04 by COX CARRIE SMITH
  • 4: filed on 2023-01-04 by DESILVA NISHAN M
  • 4: filed on 2023-01-04 by JOHNSTON LLOYD P.
  • 4: filed on 2023-01-04 by KISHIMOTO TAKASHI KEI
  • 4: filed on 2023-01-04 by SALLIN AYMERIC

    • Events (8k)

  • 8-K: filed on 2023-01-09:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-14:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-28:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-18:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-22:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-04:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-30:
    Item 8.01: Other Events
  • 8-K: filed on 2022-06-22:
    Item 8.01: Other Events

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    76.8 Thousand total shares from 17 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    TRABER PETER G CHIEF MEDICAL OFFICER

    • Officer
    		 446,121 2023-01-04 2

    JOHNSTON LLOYD P. CHIEF OPERATIONS OFFICER

    • Officer
    		 265,515 2023-01-04 2

    KISHIMOTO TAKASHI KEI CHIEF SCIENTIFIC OFFICER

    • Officer
    		 364,316 2023-01-04 2

    BRUNN CARSTEN PRESIDENT AND CEO

    • Officer
    • Director
    		 786,013 2023-01-04 8

    SPRINGER TIMOTHY A

    • Director
    • 10% Owner
    		 75,000 2023-01-02 2

    ANDO GORAN

    • Director
    		 75,000 2023-01-02 1

    COX CARRIE SMITH

    • Director
    		 107,500 2023-01-02 2

    ZENNER PATRICK J

    • Director
    		 75,000 2023-01-02 1

    BARABE TIMOTHY C

    • Director
    		 87,500 2023-01-02 2

    MYERS SCOTT DUNSETH

    • Director
    		 87,500 2023-01-02 1

    DESILVA NISHAN M

    • Director
    		 75,000 2023-01-02 1

    SALLIN AYMERIC

    • Director
    		 75,000 2023-01-02 1

    DAVIS BLAINE CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2022-11-28 2

    TAN KEVIN CHIEF FINANCIAL OFFICER

    • Officer
    		 417,000 2022-01-03 0

    DONOHUE ANN K. VP FINANCE

    • Officer
    		 4,187 2021-05-27 0

    DAHMS BRADFORD D. CHIEF FINANCIAL OFFICER

    • Officer
    		 38,000 2021-01-04 0

    KOGAN ELONA ESQ. GENERAL COUNSEL

    • Officer
    		 0 2020-01-02 0

    SMOLINSKI STEPHEN CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2020-01-02 0

    SCHECTER ALISON D. CHIEF MEDICAL OFFICER

    • Officer
    		 0 2020-01-02 0

    NASHAT AMIR

    • Director
    		 0 2019-06-14 0

    FAROKHZAD OMID

    • Director
    		 0 2019-06-14 0

    HUTT PETER BARTON

    • Director
    		 0 2018-06-15 0

    LEAMAN JOHN HAROLD CFO, TREAS. & HD CORP STRATEGY

    • Officer
    		 0 2018-06-15 0

    ABRAHAM DAVID GC, CCO & CORPORATE SECRETARY

    • Officer
    		 0 2018-06-15 0

    SANDS EARL CHIEF MEDICAL OFFICER

    • Officer
    		 7,500 2017-11-17 0

    CAUTREELS WERNER PRESIDENT AND CEO

    • Officer
    • Director
    		 321,203 2017-11-13 0

    SIEWERS DAVID CFO AND TREASURER

    • Officer
    		 0 2017-09-20 0

    KELLER PETER CHIEF BUSINESS OFFICER

    • Officer
    		 0 2017-07-07 0

    KANIA EDWIN M JR

    • Director
    		 586,595 2017-05-16 0

    TAS PARTNERS, LLC

    LEUKON INVESTMENTS, LP

    SPRINGER TIMOTHY A

    • Director
    		 1,682,604 2016-06-27 0

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP III LLC

    ISALY SAMUEL D

    • Director
    • 10% Owner
    		 1,842,797 2016-06-27 0

    FLAGSHIP VENTURES FUND 2007, L.P.

    FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

    AFEYAN NOUBAR

    • 10% Owner
    		 No longer subject to file 2016-06-27 0

    GORDON CARL L

    • Director
    • 10% Owner
    		 1,842,797 2016-06-27 0

    POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

    POLARIS VENTURE PARTNERS V, L.P.

    POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

    POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

    POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

    • 10% Owner
    		 1,903,437 2016-06-27 0

    RUSNANO

    • 10% Owner
    		 No longer subject to file 2016-06-27 0

    OSAGE UNIVERSITY PARTNERS II, L.P.

    OSAGE UNIVERSITY GP II, L.P.

    OSAGE PARTNERS, LLC

    • 10% Owner
    		 No longer subject to file 2016-06-27 0

    NANODIMENSION MANAGEMENT LTD

    NANODIMENSION LIMITED PARTNERSHIP

    • 10% Owner
    		 No longer subject to file 2016-06-27 0

    VTB CAPITAL I2BF NETHERLANDS, B.V.

    SELECTA RKFN, LTD.

    • 10% Owner
    		 No longer subject to file 2016-06-27 0

    FLAGSHIP VENTURES FUND 2007, L.P.

    FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC

    AFEYAN NOUBAR

    KANIA EDWIN M JR

    • Director
    • 10% Owner
    		 31,115 2016-06-21 0

    LANGER ROBERT

    • 10% Owner
    		 457,603 2016-06-21 0

    SHAYDULLINA LEYSAN

    • Director
    		 0 2016-06-21 0

    VON ANDRIAN ULRICH

    • 10% Owner
    		 515,494 2016-06-21 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BRUNN CARSTEN - Director - Officer PRESIDENT AND CEO

    		2023-01-06 17:16:31 -0500 2023-01-05 S 77 $1.12 d 786,013 direct 2.2556 27.0677 27.0677 5 0.0 1

    BRUNN CARSTEN - Director - Officer PRESIDENT AND CEO

    		2023-01-06 17:16:31 -0500 2023-01-05 S 13,396 $1.13 d 786,090 direct 2.2556 27.0677 27.0677 5 0.0 1

    TRABER PETER G - Officer CHIEF MEDICAL OFFICER

    		2023-01-06 17:15:28 -0500 2023-01-05 S 3,445 $1.13 d 446,141 direct 2.2556 27.0677 27.0677 5 0.0 1

    JOHNSTON LLOYD P. - Officer CHIEF OPERATIONS OFFICER

    		2023-01-06 17:16:11 -0500 2023-01-05 S 20 $1.11 d 265,515 direct 2.2556 27.0677 27.0677 5 0.0 1

    JOHNSTON LLOYD P. - Officer CHIEF OPERATIONS OFFICER

    		2023-01-06 17:16:11 -0500 2023-01-05 S 3,372 $1.13 d 265,535 direct 2.2556 27.0677 27.0677 5 0.0 1

    TRABER PETER G - Officer CHIEF MEDICAL OFFICER

    		2023-01-06 17:15:28 -0500 2023-01-05 S 20 $1.11 d 446,121 direct 2.2556 27.0677 27.0677 5 0.0 1

    KISHIMOTO TAKASHI KEI - Officer CHIEF SCIENTIFIC OFFICER

    		2023-01-06 17:15:52 -0500 2023-01-05 S 20 $1.11 d 364,316 direct 2.2556 27.0677 27.0677 5 0.0 1

    KISHIMOTO TAKASHI KEI - Officer CHIEF SCIENTIFIC OFFICER

    		2023-01-06 17:15:52 -0500 2023-01-05 S 3,372 $1.13 d 364,336 direct 2.2556 27.0677 27.0677 5 0.0 1

    TRABER PETER G - Officer CHIEF MEDICAL OFFICER

    		2023-01-06 17:15:28 -0500 2023-01-04 S 8,164 $1.13 d 449,601 direct 2.2556 27.0677 27.0677 5 0.0 1

    TRABER PETER G - Officer CHIEF MEDICAL OFFICER

    		2023-01-06 17:15:28 -0500 2023-01-04 S 15 $1.14 d 449,586 direct 2.2556 27.0677 27.0677 5 0.0 1

    KISHIMOTO TAKASHI KEI - Officer CHIEF SCIENTIFIC OFFICER

    		2023-01-06 17:15:52 -0500 2023-01-04 S 6,381 $1.13 d 367,719 direct 2.2556 27.0677 27.0677 5 0.0 1

    KISHIMOTO TAKASHI KEI - Officer CHIEF SCIENTIFIC OFFICER

    		2023-01-06 17:15:52 -0500 2023-01-04 S 11 $1.15 d 367,708 direct 2.2556 27.0677 27.0677 5 0.0 1

    JOHNSTON LLOYD P. - Officer CHIEF OPERATIONS OFFICER

    		2023-01-06 17:16:11 -0500 2023-01-04 S 6,381 $1.13 d 268,918 direct 2.2556 27.0677 27.0677 5 0.0 1

    JOHNSTON LLOYD P. - Officer CHIEF OPERATIONS OFFICER

    		2023-01-06 17:16:11 -0500 2023-01-04 S 11 $1.14 d 268,907 direct 2.2556 27.0677 27.0677 5 0.0 1

    BRUNN CARSTEN - Director - Officer PRESIDENT AND CEO

    		2023-01-06 17:16:31 -0500 2023-01-04 S 27,549 $1.13 d 799,534 direct 2.2556 27.0677 27.0677 5 0.0 1

    BRUNN CARSTEN - Director - Officer PRESIDENT AND CEO

    		2023-01-06 17:16:31 -0500 2023-01-04 S 48 $1.15 d 799,486 direct 2.2556 27.0677 27.0677 5 0.0 1

    MYERS SCOTT DUNSETH - Director

    		2023-01-04 17:06:11 -0500 2023-01-02 A 87,500 a 87,500 direct

    ANDO GORAN - Director

    		2023-01-04 17:04:42 -0500 2023-01-02 A 75,000 a 75,000 direct

    BARABE TIMOTHY C - Director

    		2023-01-04 17:04:17 -0500 2023-01-02 A 87,500 a 87,500 direct

    BRUNN CARSTEN - Director - Officer PRESIDENT AND CEO

    		2023-01-04 17:03:45 -0500 2023-01-02 A 1,275,000 a 1,275,000 direct

    BRUNN CARSTEN - Director - Officer PRESIDENT AND CEO

    		2023-01-04 17:03:45 -0500 2023-01-02 A 282,800 a 827,083 direct 6.0345 33.6207 33.6207 6 0.0 1

    COX CARRIE SMITH - Director

    		2023-01-04 17:03:06 -0500 2023-01-02 A 107,500 a 107,500 direct

    DESILVA NISHAN M - Director

    		2023-01-04 17:02:30 -0500 2023-01-02 A 75,000 a 75,000 direct

    JOHNSTON LLOYD P. - Officer CHIEF OPERATIONS OFFICER

    		2023-01-04 17:01:59 -0500 2023-01-02 A 475,000 a 475,000 direct

    JOHNSTON LLOYD P. - Officer CHIEF OPERATIONS OFFICER

    		2023-01-04 17:01:59 -0500 2023-01-02 A 100,000 a 275,299 direct 6.0345 33.6207 33.6207 6 0.0 1

    KISHIMOTO TAKASHI KEI - Officer CHIEF SCIENTIFIC OFFICER

    		2023-01-04 17:01:13 -0500 2023-01-02 A 475,000 a 475,000 direct

    KISHIMOTO TAKASHI KEI - Officer CHIEF SCIENTIFIC OFFICER

    		2023-01-04 17:01:13 -0500 2023-01-02 A 100,000 a 374,100 direct 6.0345 33.6207 33.6207 6 0.0 1

    SALLIN AYMERIC - Director

    		2023-01-04 17:00:20 -0500 2023-01-02 A 75,000 a 75,000 direct

    SPRINGER TIMOTHY A - Director - > 10% Owner

    		2023-01-04 16:59:38 -0500 2023-01-02 A 75,000 a 75,000 direct

    TRABER PETER G - Officer CHIEF MEDICAL OFFICER

    		2023-01-04 16:59:05 -0500 2023-01-02 A 900,000 a 900,000 direct

    TRABER PETER G - Officer CHIEF MEDICAL OFFICER

    		2023-01-04 16:59:05 -0500 2023-01-02 A 200,000 a 457,765 direct 6.0345 33.6207 33.6207 6 0.0 1

    ZENNER PATRICK J - Director

    		2023-01-04 16:58:13 -0500 2023-01-02 A 75,000 a 75,000 direct

    BRUNN CARSTEN - Director - Officer PRESIDENT AND CEO

    		2022-12-07 16:17:17 -0500 2022-12-05 S 4,522 $1.33 d 544,283 direct -3.125 -2.3438 41.4063 41.4063 31 -25.3906 13

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SELECTA BIOSCIENCES INC SELB 2023-02-01 21:45:03 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 21:15:04 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 20:45:03 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 20:15:04 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 19:45:04 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 19:15:03 UTC 3.8264 0.4936 2900000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 18:45:03 UTC 3.8264 0.4936 2900000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 18:15:03 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 17:45:04 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 17:15:03 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 16:45:03 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 16:15:03 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 15:45:04 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 15:15:04 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 14:45:04 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 14:15:04 UTC 3.8264 0.4936 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 13:45:03 UTC 3.6828 0.6372 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 13:15:04 UTC 3.6828 0.6372 4100000
    SELECTA BIOSCIENCES INC SELB 2023-02-01 12:45:03 UTC 3.6828 0.6372 4100000
    SELECTA BIOSCIENCES INC SELB 2023-01-31 22:15:03 UTC 3.6828 0.6372 3400000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments